Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corneal Persistent Epithelial Defect”

16 trials

Showing 16 of 16 results

Testing effectiveness (Phase 2)Ended earlyNCT05727878
What this trial is testing

Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED

Who this might be right for
Persistent Corneal Epithelial Defect
Combangio, Inc 103
Testing effectiveness (Phase 2)Study completedNCT02979912
What this trial is testing

Autologous Platelet Lysate in Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defect
Hanan Jafar 10
Testing effectiveness (Phase 2)Looking for participantsNCT06919081
What this trial is testing

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Who this might be right for
Persistent Corneal Epithelial DefectCorneal Epithelial Disorders
University of Illinois at Chicago 24
Testing effectiveness (Phase 2)WithdrawnNCT00821561
What this trial is testing

Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects

Who this might be right for
Persistent Epithelial Defect
OcuNexus Therapeutics, Inc. 90
Testing effectiveness (Phase 2)WithdrawnNCT05172349
What this trial is testing

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Who this might be right for
Corneal UlcerPersistent Corneal Epithelial Defect
TBF Genie Tissulaire
Testing effectiveness (Phase 2)Ended earlyNCT04081103
What this trial is testing

NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries

Who this might be right for
Corneal Persistent Epithelial Defect
Glaukos Corporation 35
Not applicableWithdrawnNCT02395952
What this trial is testing

Healing of Persistent Epithelial Defects

Who this might be right for
Cornea
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT05066698
What this trial is testing

ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defect
Noveome Biotherapeutics, formerly Stemnion 8
Not applicableStudy completedNCT00238862
What this trial is testing

Treatment of PED With AMT and Autologous Serum

Who this might be right for
Corneal Epithelial Defect
King Khaled Eye Specialist Hospital 180
Testing effectiveness (Phase 2)Study completedNCT03687632
What this trial is testing

ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defect
Noveome Biotherapeutics, formerly Stemnion 13
Testing effectiveness (Phase 2)Looking for participantsNCT05966493
What this trial is testing

Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Who this might be right for
Persistent Corneal Epithelial Defect
Glaukos Corporation 84
Not applicableLooking for participantsNCT03653650
What this trial is testing

Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects

Who this might be right for
Persistent Epithelial Defect
Universidad Autonoma de Nuevo Leon 54
Testing effectiveness (Phase 2)Study completedNCT05436288
What this trial is testing

The KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defect
Kiora Pharmaceuticals, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00988494
What this trial is testing

Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect

Who this might be right for
Persistent Corneal Epithelial Defect
Santen Pharmaceutical Co., Ltd. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06999733
What this trial is testing

A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Krystal Biotech, Inc. 27
Testing effectiveness (Phase 2)Ended earlyNCT01165450
What this trial is testing

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

Who this might be right for
Persistent Corneal Epithelial Defects
University of California, San Francisco 2

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation